Metastasis-directed therapy and prostate-targeted therapy in oligometastatic prostate cancer: a systematic review.
CONCLUSIONS: We performed a comprehensive overview of the current literature on MDT and PTT. The feasibility of MDT and PTT is supported by several retrospective studies. Nevertheless, there remains a lack of high-quality trials to prove its survival benefits. Results from ongoing prospective trials data are awaited.
PMID: 32550632 [PubMed - as supplied by publisher]
Source: Minerva Urologica e Nefrologica - Category: Urology & Nephrology Tags: Minerva Urol Nefrol Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Databases & Libraries | Prostate Cancer | Prostatectomy | Radiation Therapy | Science | Study | Urology & Nephrology